Granite Bio Innovation

When her son Leo was born with a terrible genetic illness, Yiwei She created an individualized gene therapy: “Leosen”. We’re fighting to make New Hampshire a hub for therapies like Leo’s. We’re proud to welcome Yiwei to our conference on August 20. GraniteBio.org/820

New Hampshire has the potential to become a national hub of frontier biotechnology through policy innovation. Gov. @KellyAyotte has become a powerful voice for emerging biotech. We're proud to welcome her to Bio Innovation Day on August 20. GraniteBio.org/820

We're proud to announce that scientist and investor Siranush Babakhanova Nobile has joined our board of directors. Siranush is a General Partner at Fundomo, an early-stage deep tech venture firm she co-founded, with a portfolio that includes companies in biotechnology, computing, and defense. Her scientific career includes research in deep brain imaging with the Synthetic Neurobiology Group at MIT, biotech tool development with the Snyder Lab at Stanford—where she studied biophysics as a Knight-Hennessy Scholar—and exoatmosphere simulations at NASA. She is the co-founder of Xapiens, a human augmentation and brain-machine interface initiative, an NSF Graduate Research Fellow, and a Hertz Foundation Fellowship finalist.

@raechellambert BUILD

We're buying 100+ acres of land and developing it into an innovation district for entrepreneurs to live and work. It will be in New Hampshire and it's called Freedom Village. We're unveiling our plans for the first time at Freedom Summit Aug 20-21 where we will gather builders across science, energy, startups, AI, housing and community. Join us to live free and build the future in New Hampshire. Comment BUILD and I'll DM you the link. @jhitchco

New Hampshire has built a stronger movement for frontier biotech than any other state in America. Now we’re going to build the future of human flourishing right here in the Granite State. Join us for Bio Innovation Day on August 20—apply at GraniteBio.org/820

At Power Hour this week: Rep @mdrew4nh showed us we need to think about the State Budget NOW, not later. Genesis Lung: “We weren’t meant to trash sick embryos, we were meant to fix them. Prenatal gene therapy is now a possibility.” Support right to try ❤️

Please join us this Friday, June 12, at 11:30am for NHLA Power Hour! At @AFP_NH in Manchester. Two guest speakers this week: 🏛️ Rep. Matt Drew @mdrew4nh presenting "State Budget Basics: Finding the Fat" 🧬 Genesis Lung presenting "A World Without Inherited Disease: Preventive Prenatal Care" 🗽RSVP for LUNCH!

@JoeSweeneyNH Thank you for your incredible leadership on this issue. Save the date for our August 20 conference!

@GraniteBio I'm in this fight for the long haul. Such a great opportunity for our state to lead and build the future here.

A version of HB 1735 passed the NH Senate today. The version was heavily amended and, unfortunately, will not enable New Hampshire to become a commercial-scale hub for experimental therapies. Granite Bio Innovation attempted to accept most of the Senate’s amendment while pursuing minimal changes that would allow a modest step in the right direction. Regrettably, these discussions did not produce a workable pathway for any of the firms and patients we support. We will continue to support New Hampshire's patients and innovators in the following ways: • Shaping other areas of state legislation in a way that facilitates frontier biotechnology in New Hampshire. • Advocating for state and federal regulatory policy that allows New Hampshire's biotech ecosystem to flourish. • Serving as a nexus for innovators and pro-biotech policymakers, including through an annual conference in August and by providing resources to healthcare providers. Follow Granite Bio Innovation to stay in touch and learn more about how you can get involved. We are grateful to the many New Hampshire officials who have championed the state's promise as a biotech hub, including Governor @KellyAyotte and @NHSpeaker for supporting the passage of Right to Try reforms as part of SB 504. Across the US, momentum is growing for policy reforms that allow experimental therapies. These reforms will come from both federal agencies and state legislatures. It remains to be seen which states will lead the way.

.@NHSpeaker on Senate rejecting last week expanded Right to Try Act. "The Senate declined to pursue this legislation, turning down billions of dollars of economic activity and shutting down the expansion of health and wellness pathways for every Granite Stater." #nhpolitics

Sad to hear of former Rep. Michael Yakubovich’s passing. He inspired us all with his bravery and advocacy for fellow patients battling rare diseases. Joe and I are praying for Michael’s wife Marika, his family, and his friends and former colleagues.

@jimbyrdpmm Learn more here! granitebio.org/legislation

@GraniteBio How would this bill add to therapies already available in places like Boston?

The NH Senate has again rejected Right to Try, shutting the door on patients seeking experimental treatments. A few state senators have decided that New Hampshire is closed for business to biotech firms offering frontier therapies. Here's what happened and our next steps. This term, a bipartisan majority of the state House passed HB 1734 and HB 1735: two bills to make New Hampshire the best state in America for experimental therapies. The bills were based largely on existing laws in Montana and Florida. Granite Bio Innovation—and the businesses and patients we support—helped build a coalition across every branch of elected state government to support these bills. We also worked for several months to build consensus in the Senate. Senators received calls from patients, businesses, investors, scientists, and healthcare providers supporting the bills. After Senator David Rochefort requested a long list of changes to HB 1734, the biotech firms involved agreed to every change. But these negotiations were not in good faith. Senator Rochefort abruptly decided he would not accept any version of the bills, and the Senate rejected both. The New Hampshire House then attached both bills to Senate Bill 504—this time with an even broader bipartisan vote of 197 to 145. Rather than negotiate a compromise, the Senate decided to fight this bill at any cost. Sadly, there is no pathway for making New Hampshire a commercial-scale hub for experimental therapies until the composition of the NH Senate changes. Until then, Granite Bio Innovation will continue to support New Hampshire's patients and innovators in the following ways: • Shaping other areas of state legislation in a way that facilitates frontier biotechnology in New Hampshire. • Advocating for state and federal regulatory policy that allows New Hampshire's biotech ecosystem to flourish. • Serving as a nexus for innovators and pro-biotech policymakers, including through an annual conference in August and by providing resources to healthcare providers. We are grateful to the many New Hampshire officials who have embraced the state's promise as a biotech hub, including @NHHouseGOP leadership, Governor @KellyAyotte, Mayor @JayRuais, and those senators who supported Right to Try on the Senate floor. We are especially grateful to @NHSpeaker for sponsoring the amendment to SB 504 and to Representatives @KesselringSteve and @cole4nh for their tireless leadership on these bills and courageous stand for patients in need. With a biotech revolution approaching, a US state will soon become a hub for experimental therapies. The only question now is which one.

As a NH legislator and MS warrior of 25 years, I was in full support of this bill. Those of us with debilitating chronic illness deserve to be given the opportunity to live a fuller life. We know the risks and are willing to accept them to lessen our suffering.

We moved the conversation forward after a year of work in the House to advance these bills for patients suffering from rare diseases and to push forward the future of medical innovation. The Senate made the wrong decision today, choosing not to stand with patients and not to support the kind of breakthrough treatments that can save lives. As a campaign promise in my run for Congress, I will always fight for patients’ ability to live and for families to have real hope through access to breakthrough treatments, experimental options, and medical innovation that can change lives. I will not accept a system that leaves people waiting when time is not on their side. Every person deserves the chance to save their own life, and I will take that fight to Washington.

@YellowSubm45706 These bills would have authorized patient-facing clinics, not biolabs.

@GraniteBio I think we need to be more careful with Biolabs in general. They are not safe to surrounding communities

@LeahCushmanNH Run for NH Senate instead.

@LeahCushmanNH Individualized gene therapies and regenerative stem cell treatments would have made up most of the therapies, followed by personalized cancer therapies. #patients-need-rtt" target="_blank" rel="nofollow noopener">granitebio.org/legislation#pa…